Search

everythinglearnresearchcommunity

for

Search:↓

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

Follicular red dots may be a normal feature seen in people with less skin pigmentation, not necessarily indicating a scalp disorder.

The compound 4c showed strong potential as an anticancer agent.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Biotin supplements may improve hair and nail growth in people with certain deficiencies or conditions, but there's not enough evidence to recommend it for healthy individuals.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

Using steroids can increase the risk of heart problems.

The document concludes that recognizing oral lesions is important for diagnosing syphilis.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Hedgehog signaling is crucial for mammary gland development over hair follicles.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.